A deeper and more comprehensive understanding of how FABP4 signaling is involved in obesity-associated tumors could improve the potential of developing new therapeutic targets and strategies for tumor treatment. Here, FABP4 is linked to obesity due to melanocortin 4 receptor deficiency.